GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cambridge Nutritional Sciences PLC (FRA:RVKA) » Definitions » Enterprise Value

Cambridge Nutritional Sciences (FRA:RVKA) Enterprise Value : €7.25 Mil (As of Jun. 09, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cambridge Nutritional Sciences Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cambridge Nutritional Sciences's Enterprise Value is €7.25 Mil. Cambridge Nutritional Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was €-3.52 Mil. Therefore, Cambridge Nutritional Sciences's EV-to-EBIT ratio for today is -2.06.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Cambridge Nutritional Sciences's Enterprise Value is €7.25 Mil. Cambridge Nutritional Sciences's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was €-2.86 Mil. Therefore, Cambridge Nutritional Sciences's EV-to-EBITDA ratio for today is -2.53.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Cambridge Nutritional Sciences's Enterprise Value is €7.25 Mil. Cambridge Nutritional Sciences's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was €10.38 Mil. Therefore, Cambridge Nutritional Sciences's EV-to-Revenue ratio for today is 0.70.


Cambridge Nutritional Sciences Enterprise Value Historical Data

The historical data trend for Cambridge Nutritional Sciences's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambridge Nutritional Sciences Enterprise Value Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 166.02 5.65 2.37

Cambridge Nutritional Sciences Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.07 5.65 2.76 2.37 0.38

Competitive Comparison of Cambridge Nutritional Sciences's Enterprise Value

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cambridge Nutritional Sciences's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's Enterprise Value falls into.



Cambridge Nutritional Sciences Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Cambridge Nutritional Sciences's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as

Cambridge Nutritional Sciences's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cambridge Nutritional Sciences  (FRA:RVKA) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Cambridge Nutritional Sciences's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=7.247/-3.52
=-2.06

Cambridge Nutritional Sciences's current Enterprise Value is €7.25 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Cambridge Nutritional Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was €-3.52 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Cambridge Nutritional Sciences's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=7.247/-2.861
=-2.53

Cambridge Nutritional Sciences's current Enterprise Value is €7.25 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Cambridge Nutritional Sciences's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was €-2.86 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Cambridge Nutritional Sciences's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=7.247/10.383
=0.70

Cambridge Nutritional Sciences's current Enterprise Value is €7.25 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Cambridge Nutritional Sciences's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was €10.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cambridge Nutritional Sciences Enterprise Value Related Terms

Thank you for viewing the detailed overview of Cambridge Nutritional Sciences's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cambridge Nutritional Sciences (FRA:RVKA) Business Description

Traded in Other Exchanges
Address
One Fleet Place, London, GBR, EC4M 7WS
Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition. The company develops, manufacture and market pioneering diagnostic products associated with food sensitivity and gut health. These products enable healthcare practitioners to make informed decisions that can transform their patients' long-term health.

Cambridge Nutritional Sciences (FRA:RVKA) Headlines

No Headlines